Bone tissue healing is a dynamic process that is initiated by the recruitment of osteoprogenitor cells followed by their migration, proliferation, differentiation, and development of a mineralizing extracellular matrix. The work aims to manufacture a functionalized porous membrane that stimulates early events in bone healing for initiating a regenerative cascade. Layer-by-layer (LbL) assembly is proposed to modify the surface of osteoconductive electrospun meshes, based on poly(lactic-co-glycolic acid) and nanohydroxyapatite, by using poly(allylamine hydrochloride) and poly(sodium 4-styrenesulfonate) as polyelectrolytes. Molecular cues are incorporated by grafting peptide fragments into the discrete nanolayers. KRSR (lysine-arginine-serinearginine) sequence is grafted to enhance cell adhesion and proliferation, NSPVNSKIPKACCVPTELSAI to guide bone marrow mesenchymal stem cells differentiation in osteoblasts, and FHRRIKA (phenylalanine-histidinearginine-arginine-isoleucine-lysine-alanine) to improve mineralization matrix formation. Scanning electron microscopy, infrared spectroscopy, and X-ray photoelectron spectroscopy demonstrate the successful surface functionalization. Furthermore, the peptide incorporation enhances cellular processes, with good viability and significant increase of alkaline phosphatase activity, osteopontin, and osteocalcin. The functionalized membrane induces a favorable in vivo response after implantation for four weeks in nonhealing rat calvarial defect model. It is concluded that the multilayer nanoencapsulation of biofunctional peptides using LbL approach has significant potential as innovative manufacturing technique to improve bone regeneration in orthopedic and craniofacial medical devices.
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incorporating biomolecules such as extracellular matrix (ECM) proteins or short peptide fragments via surface modification or bulk incorporation. They have the potential to interact with cells, promoting desirable cellular activities, i.e., adhesion, proliferation, and differentiation. [1] Bone morphogenetic proteins (BMPs) are the largely used growth factors involved in the improvement of bone regeneration, [2] showing their potential to differentiate mesenchymal stem cells into osteogenic cells. [3] However, there are a number of issues surrounding the use of full proteins in the body, that include: folding randomly, dose, price, susceptibility to degradation, immunogenicity, and purification. [4] Therefore, short peptide chain represents a viable alternative to these problems related with full protein use and can reciprocate the signaling and binding domains of the long chain proteins. Short peptides are characterized by reduced manufacturing cost and purification time as well as they are much more stable and resistant than long protein to pH and thermal changes. [5] Since the discovery of the arginine-glycine-aspartic acid (RGD) sequence in fibronectin 30 years ago, [6] there has been a vast array of proteins found in bone with high number of cellular interactions possible through the different cell adhesion receptors. Recently, Gentile et al. proposed two identified peptide fragments, FHRRIKA (phenylalanine-histidine-arginine-arginine-isoleucine-lysine-alanine) and KRSR (lysine-arginine-serine-arginine) for grafting scaffolds surfaces for bone regeneration. [7] It has been reported in literature that KRSR sequence, identified in different adhesive proteins related with bone (i.e., fibronectin, vitronectin, bone sialoprotein) is suitable for enhancing the osteoblast adhesion to scaffold surfaces. [8] Dee et al. have demonstrated a comparable adhesion of osteoblasts on surfaces modified by incorporation of KRSR and RGD. [9] Furthermore, several studies described that FHRRIKA sequence, derived from bone sialoprotein, supported the matrix mineralization. [10] Interestingly, as reported by Schuler et al., RGD combined with FHRRIKA or KRSR caused improved osteoblast activities. [11] Other short peptide fragments proposed
Introduction
Biomimetic scaffolds are ideal for bone regeneration due to their ability to mimic the native extracellular matrix environment by in literature for bone regeneration are the hexapeptide fragment GFOGER, extracted from collagen (type I), that stimulates the differentiation of osteoblasts [12, 13] and the C-terminal pentapeptide YGFGG, derived from the osteogenic growth peptide ALKRQRT-LYGFGG, corresponding to the C-terminal of histone H4, able to stimulate the proliferation and alkaline phosphatase activity (ALP) of MC3T3 osteoblast-like cells. [13] Finally, the long peptide sequences, such as NSPVNSKIPKACCVPTELSAI derived from BMP-2, showed their potential to induce osteogenesis in vivo. [13, 14] However, the overall number of peptide fragments used in bone can increase by using combinations of the bone peptide sequences. The interactions between peptides or peptide combinations and cells are not yet fully understood.
The most established methods proposed in the literature are to graft short peptide sequences by adsorption [15] or chemical grafting (by click-chemistry or carbodiimide). [16] Although, traditional chemistry has been widely used to functionalize constructs with peptides, it does not allow creation of 3D gradient peptide structures. In this work, we propose an alternative method, called layer-by-layer (LbL) assembly to build up peptide gradients in order to modulate at nanoscale cellular response and induce faster bone formation. LbL technique is based on the alternating exposure of positive and negative solutions of charged polymers called polyelectrolytes (PEs). It is an inexpensive, aqueous, conformal method for the creation of nanolayered coatings with custom-made composition and structure, showing a large range of optical, electrical, and biological properties. [17] [18] [19] Due to its versatility and simplicity for incorporating high loadings of different types of biomolecules with a fine control over multilayer structure, LbL provides a rational method toward the control of specific biological activities. Recently, Zhou et al. prepared electrospun mesh, based on cellulose acetate, modified by LbL in order to enhance antibacterial and antioxidative properties. Silver nanoparticles-lysozyme compound and tannic acid (AgNPs-Lys/TA) n were used as a formula to obtain the multilayered coating, where n was the number of the AgNPs-Lys/TA bilayers. The outermost layer was Lys composite when n equaled to 5.5 and 10.5. These mats revealed to be suitable in the areas of food packing, tissue engineering, and wound dressing. [20] Moreover, layer-by-layer has been used to investigate the in situ differentiation of mesenchymal stem cells (MSCs) into mature osteoblasts on titanium films, by using chitosan and plasmid DNA (pEGFP-hBMP-2) as polyelectrolytes. Compared with control groups, MSCs cultured onto LbL-modified titanium films displayed higher production levels of alkaline phosphatase and osteocalcin over 7 and 14 d culture, respectively. [21] Therefore, LbL is highly attractive as a route to functionalize biomaterials or devices that would otherwise be incapable of stimulating specific biological processes or enhanced healing. While the research reviewed above has shown the potential for LbL to deliver small molecules that retained their functionality, to date the stimulation of anabolic biological processes by nanoencapsulated peptides has not been reported. In this work, we proposed the LbL method to modify osteoconductive electrospun composite membranes (based on poly(lactic-co-glycolic acid) (PLGA) and nanohydroxyapatite) in order to impart a cascade of stimuli at the nanoscale and to control the adhesion, proliferation, and differentiation of mesenchymal stem cells, and the formation of new bone matrix. [22] LbL allows to create a peptide gradient, where the cells, according to the dissolution of the multilayered coating, can interact subsequently with the different peptide sequences (Figure 1A,B) for: (1) enhancing their adhesion, spreading, and proliferation (interaction with KRSR grafted on the top nanolayers), (2) guiding their differentiation in osteoblasts (NSPVNSKIPKACCVPTELSAI grafted to the middle nanolayers), and (3) improving the formation of mineralization matrix (FHRRIKA on the bottom nanolayers). The biocompatibility and osteogenic response has been evaluated in vitro studying bone marrow mesenchymal stem cell differentiation in osteoblasts and in vivo using nonhealing rat calvarial defect model.
To summarize, it is the final aim of this work to manufacture a biomimetic construct using LbL technology to simulate and so initiate a physiological bone healing cascade. If successful, this approach could find wide application as a simple and reliable method to modify a wide range of medical devices where stimulation of bone tissue regeneration was clinically challenging and necessary.
Results and Discussion
A summary of the experiments is reported in Figure 1 . The multilayered structure was fabricated by layer-by-layer after accurate optimization of the process parameters (panel A). Specific bone peptides were grafted to the positive charged polyelectrolytes in order to mimic the "bone healing" cascade (panel B). The osteogenic potential was measured in vitro after seeding rat bone marrow mesenchymal stem cells (BM-MSCs) (panel C) on the membrane surface and in vivo using a rat calvarial bone model (panel D).
In this work, composite membranes, based on PLGA and nanohydroxyapatite (nHA), have been obtained by electrospinning. This conventional method has been widely accepted as the simple and less expensive method to fabricate random or aligned fibrous matrices through the extrusion of the solution from a needle by a high voltage electric field. [23] By tuning electrospinning processing parameters, it is possible to modify fiber morphology and dimensions to enhance the spun morphology for promoting a positive cellular response. [24] After optimization of the process parameters (solution concentration 20%, voltage 20 kV, distance 18 cm, and flow rate 2.5 mL h −1 ), smooth nanoand microfibers were formed with the occurrence of some nHA aggregates, with a size ranging from 800 nm to 1.4 µm (Figure 2A) .
For mimicking the cascade of bone healing, the LbL approach has been used for obtaining a multilayered coating on the electrospun membranes in order to graft appropriate bone peptide sequences to the nanolayers ( Figure 1A ). Furthermore, 14 layer was chosen as final number after optimization of several process parameters: number of layers (10, 14, and 20 ( Figure S1 , Supporting Information)), dipping time into the PE solutions (10 and 15 min), polyelectrolytes' molar concentration (0.25 and 0.5 m), and bone peptide sequences' grafting (several combinations within the multilayers).
An optimized peptide gradient has been created after grafting to poly(allylamine hydrochloride) (PAH): KRSR (from (3 of 11) 1601182 layer 10 to 14) to enhance cell adhesion, spreading, and proliferation, [11] NSPVNSKIPKACCVPTELSAI (from layer 6 to 10) to guide BM-MSC differentiation in osteoblasts, [12] and FHRRIKA (from layer 2 to 6) to improve the formation of mineralization matrix. [11, 12] Furthermore, the small amount of peptide grafted on the PAH did not influence the ζ-potential of the solution (+14.6 mV with respect to +14.9 mV of pure PAH), while poly(sodium 4-styrenesulfonate) (PSS) solution was always negatively charged with ζ-potential of −18.6 mV.
Finally, the osteoconductive nanohydroxyapatite in the electrospun mesh is present to influence the cells to maintain the new osteoblast-like phenotype and guide their growth along the fiber orientation. [25] The manufactured membranes were coded with the corresponding number of the last layer created, following with "_P" if the bone peptide sequences were grafted to PAH.
The surface morphology of the multilayered coating after LbL assembly was analyzed by scanning electron microscopy (SEM) ( Figure 2B ). The membranes presented an average fiber diameter of 1.7 ± 0.5 µm, without compromising the microporosity for nutrient transport, making available biocues of the native ECM. [26] Successful immobilization of PSS and PAH grafted with peptides was monitored by several techniques although qualitative and semiquantitative information were provided. Specifically, energy dispersive spectroscopy (EDS) proved the formation of the multilayer coating by the difference in the amount of sulfur and nitrogen ( Figure 3A,B) . For 14L_P membrane, S and N content were 8.8 ± 0.5 and 5.5 ± 0.3 wt%, considerably higher than the amounts detected in the uncoated mesh (0.1 wt% for sulfur and 0.5 wt% for nitrogen). Furthermore, the maps ( Figure 3B (ii)) evidenced a uniform distribution of sulfur (pink dots) and nitrogen (green dots) on the membrane surface, that was not observed for pure composite meshes, where calcium (red dots) and phosphorous (blue dots) elements were present only ( Figure 3A (ii)).
X-ray photoelectron (XPS) and Attenuated Total Reflectance -Fourier Transform Infrared (ATR-FTIR) spectrocopies were performed to analyze the surface composition of the membranes before and after LbL assembly. Particularly, Figure 4A shows the XPS survey spectra after aminolysis treatment (PLGA/nHA_am) and after the obtainment of 1, 4, and 14 layers. The surveys showed the characteristic S 2p peak at 168 eV and N 1s peak at 399.5 eV, demonstrating PSS and PAH have been successfully introduced.
The resulting atomic percentage of the main characteristic elements of the coating (C1s, O1s, N1s, and S2p) and the atomic ratio S/N with the increase of layer number has been calculated and reported in Table 1 . XPS confirmed again the realization of the multilayer where the content of nitrogen and sulfur increased. Moreover, the S/N atomic ratio had an alternating regular trend, suggesting modifications in the surface chemical composition after LbL assembly. Particularly, S/N ratio was higher with the PSS as top layer where sulfur was the representative chemical element of PSS and nitrogen was for PAH. Similar results were observed previously by the same authors, after functionalizing PLGA dense film by LbL assembly (using the same PEs of the current work) to impart antimicrobial activity after incorporation of an antibiotic drug. [19] Notwithstanding, the presence of the peptides was influencing slightly the values of nitrogen content in the even layers, due to their low amount grafted to PAH (data not shown).
The high resolution spectra for C 1s along with the curve fit ( Figure 4B ) show three peaks attributed to the different carbon oxidation states: (1) 284.7-285.0, (2) 286.8-287.0, and (3) 288.5-289 eV, corresponding to CH or CC bonds, to CO bond, [27] and to NCO (amide) groups, [28] respectively. Moreover, from Table 1 that summarizes all the data, it is observed that these components' content varied significantly. The concentration of NCO (23.5 ± 1.4% for the aminolyzed sample) decreased drastically with the increased layer number (4.2 ± 1.1% for 14L_P). For the coated sample, the component at 284.7 eV corresponding to CC bonds increased, reaching a final value of (83.0 ± 2.3%) and the component at 286.9 eV attributed to CO bonds decreased, reaching a final value of (11.8 ± 1.2%), suggesting the PE coating. 
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Furthermore, the infrared spectra shown in Figure 5A revealed the presence of the characteristic chemical bands of the polyelectrolytes: for poly(sodium 4-styrenesulfonate): νOH stretching of the adsorbed water (frequency range 3700-3000 cm −1 ), aromatic νCH stretching (3100 cm −1 ), alkyl νCH stretching (2920 cm −1 ), aromatic δCH bending (1800 and 1925 cm −1 ), νOH bending vibrations of absorbed water (1640 cm −1 ), aromatic νCC stretching (1600, 1500, 1450, and 1410 cm −1 ), νSO 3 − symmetric and asymmetric stretching (1040-1005 and 1190-1130 cm −1 , respectively). [29] Poly(allylamine hydrochloride was characterized by the following chemical bands: νNH stretching (3360 cm −1 ), alkyl νCH stretching (2920 cm −1 ), NH symmetric and asymmetric scissoring vibrations (1490 and 1580 cm −1 , respectively), and νNH asymmetric stretching (1330 cm −1 ). [29] Finally, the presence of the peptide grafting into nanolayered structure has been indicated by the typical absorption peaks of the amide I and II at 1650 and 1520 cm −1 , respectively). [30] Amide A and III of the peptides' typical bands were not clearly observed because the polyelectrolyte bands caused an overlap.
In vitro dissolution tests have been performed for testing the coating stability. ATR-FTIR spectra were obtained after two, four, and six weeks of immersion in phosphate buffer saline (PBS).
Figure 5B-D shows that the intensity of the characteristic chemical bands of PSS, PAH, and peptide sequences decreased with the increase of immersion time. Particularly, after two and four weeks, a dissolution degree of ≈35% and ≈75%, respectively, was calculated. Finally, after six weeks, only weak absorption peaks of the corresponding polyelectrolytes were noticed, suggesting a complete dissolution of the coating. The dissolution measured is in accordance with the time required for the osteoblastogenesis in vitro. [31] The presented design of the functionalized membranes was proposed after combination of several process variables and characterizing not only by physicochemical characterization but also by analyzing cells behavior (as reported in the . XPS spectra after functionalization by layer-by-layer assembly. A) Survey spectra and B) deconvoluted C1s spectra for pure composite membrane after aminolysis and after coating of 1, 4, and 14 layers, respectively. Supporting Information also). In this study, we used bone marrow-derived mesenchymal stem cells, the best characterized cells to represent adult stem cell population capable of differentiation into various lineages. [32] The BM-MSCs were extracted from rats according to the protocol proposed by Santocildes-Romero et al. [33] and were seeded on uncoated and coated membranes. Designing and manufacturing a biocompatible material is one of the most challenging key features for the in vivo scaffold implantation. Therefore, several approaches have been described in literature for modifying successfully the surface of scaffolds, such as by physical absorption, encapsulation, chemical treatment, and ionic or covalent binding. [34] However, the encapsulation and physical absorption are characterized by weak biomolecules' stability due to their fast release when the functionalized scaffolds are implanted in vivo for a medium and long-term. In addition, the entrapped biomolecules present poor resistance to shear stress of the fluids. [34] The LbL assembly is a versatile and environmental-friendly method, widely used in many fields, that allows the immobilization of different biomolecules to impart specific biological activities. Moreover, in this work, the covalent immobilization of bone peptide sequences permits to avoid the removal of the grafted biomolecules by washing. [18] Biocompatibility tests were performed to evaluate whether the polyelectrolytes and the grafting between PAH and peptide sequences affected the BM-MSC viability and proliferation. PrestoBlue analysis (Figure 6A) showed that BM-MSCs in both coated membranes with and without peptides exhibited a higher metabolic activity comparable with the control after 3 and 7 d. In the case of 14L_P sample, the cells displayed a significant higher metabolic activity (i.e., after 7 d of cell seeding, normalized fluorescence units for 14L_P and 14L were 0.243 ± 0.021 and 0.152 ± 0.018).
Therefore, the addition of the peptide sequences affected dramatically the adhesion and metabolic activity of BM-MSCs in a short-term period, and particularly the authors found 40% more viability on membrane with KRSR grafted to the top layer in comparison with FHRRIKA and NSPVNSKIPKAC-CVPTELSAI (see Figure S2 in the Supporting Information). Sun et al. described also the role of KRSR influence, where the MC3T3-E1 attachment and osteogenic differentiation were improved significantly on the TiO 2 anodized nanotube-layers grafted with KRSR for orthopedic and dental implant applications. [35] Moreover, Schuler et al. reported that scaffold surfaces modified with KRSR sequence preferred osteoblast-like cells in comparison with fibroblasts or endothelial cells in terms of cell proliferation. [11] It is commonly accepted that changes of alkaline phosphatase activity in bone cells are associated with a change of the differentiated state. Generally, an increase of ALP enzyme activity is correlated with bone formation, increasing during the bone formation stage. [36] Not surprisingly, the ALP quantification data ( Figure 6B ) showed significantly higher activity levels when cells were cultured under osteogenic media rather than basal media. However, at days 14 and 21, the levels of ALP activity on 14L_P under basal media cultures are significantly higher than PLGA/nHA and 14L membranes (i.e., at day 21 under basal media culture, the grafting of the peptide has significantly (*p < 0.05) higher ALP activity levels (0.046 ± 0.004) with respect to pure composite membrane (0.024 ± 0.003)). Although PLGA/nHA and 14L membranes are not capable of inducing the ALP protein expression alone, they were capable of improving the ALP expression during the differentiation process of BM-MSCs to osteoblasts under osteogenic media condition for 21 d of culture.
In addition to the reported biological data, the differentiation level of BM-MSC under basal or osteogenic media was assessed by quantitative expression of two major bone-specific proteins, namely, osteopontin (OP) and osteocalcin (OC). The relative expression of those proteins was normalized with respect to the cell proliferation ( Figure 6C,D) . It is well described that osteoblasts are differentiated cells that mineralize the bone matrix. OP that is synthesized by bone forming cells, is a phosphoprotein, which has calcium-binding domains and is responsible for cell attachment, proliferation, and ECM mineralization. [37] While OC is a bone-specific glycoprotein capable of binding with calcium, which promotes ECM calcification. [38] Not surprisingly as described for ALP activity, the OP and OC evaluation showed significantly higher protein expression levels when BM-MCSs were cultured under osteogenic media rather than basal media. [38] In the case of OP, as expected, a delay in the protein synthesis is observed ( Figure 6C ). At day 7, there was no significant difference in OP expression with respect to the The most important peaks of the nanocoating are evidenced in a colored area: PSS in beige, PAH in green, and the bone peptide sequences in blue color, respectively.
(7 of 11) 1601182 pure composite membrane under basal and osteogenic conditions. However, at day 14, there is the highest expression peak for osteogenic media cultures, which indicates the beginning of the mineralization phase. Specifically, under osteogenic media, all the sample showed a significant (*p < 0.05 for PLGA/nHA and 14L) and extremely significant (**p < 0.001 for 14L_P) overexpression. To emphasize, all the samples under osteogenic conditions and the 14L_P membrane under basal condition showed a significant overexpression of OP protein at day 21, supporting the higher ALP activity. For OC evaluation, there was a high protein expression up to day 14 ( Figure 6D ), indicating bone ECM maturation. [39] At day 7, there is a significant difference of OC expression with respect to the control (PLGA/ nHA under basal medium conditions). PLGA/nHA and 14L_P membranes showed the OC overexpression capacity at 14 and 21 d, representing significant differences over the control. Notable is that 14L_P under basal media condition exhibited a peak of expression at day 21, suggesting that this membrane was able to induce in long-term OC protein expression, which corroborates the ALP data.
Finally, preliminary in vivo tests using a rat calvarial model were performed. After four weeks of implantation, there was increased new bone formation when a construct was utilized compared to sham operated sites with no construct ( Figure 7A and Movie S1 (Supporting Information)). Micro-CT investigation indicated that the volume percentage of new formed bone in the defect treated with PLGA/nHA, 14L, and 14L_P were 13.7% ± 3.6%, 15.8% ± 4.1%, and 24.6% ± 3.8%; thus, all membranes let to an improved healing in comparison with the subject matched empty defect in which the volume percentages of new bone were 7.7% ± 1.9%, 8.5% ± 2.8%, and 9.4% ± 2.2%, respectively ( Figure 7B -D and Movies S2-S4 (Supporting Information)). While these increases did not show significant differences between the constructs, it suggests that they could encourage bone healing and that any significant difference between them was not evident at this single time point. When compared to other studies reported in literature using pure membranes based on PLGA/collagen/HA or collagen/HA, the volume percentage of new formed bone in the defect treated with 14L_P was higher (≈25% respect to ≈6%-10%) after four weeks of implantation. [40] Moreover, the trend in the formation of new bone was found also comparable with more sophisticated membrane, described in literature, where a scaffold sheet of medical grade polycaprolactone/tricalcium phosphate/collagen was functionalized with the addition of BMP-2 and, then implanted in cranial model. [ composite membrane (from ≈12 to ≈19 mm 3 of bone volume). Therefore, the biomimetic approach of functionalizing scaffolds with the addition of proper biomolecules can be considered a promising and cheaper alternative to tissue engineered cell-polymer constructs. [42] Histological assessment of the rat calvaria was performed on completion of micro-CT examination. Hematoxylin and eosin-stained sections were examined using conventional light microscopy. New bone was noted at the periphery and center of the defects for 14L_P sample ( Figure 7H) , as opposed to the other groups ( Figure 7F ,G, PLGA/nHA and 14L), where new bone was restricted to the margins. The histological findings in terms of distribution of new bone were consistent with the appearances noted on micro-CT and lend support for the usefulness of this image modality in the assessment of bone response to novel materials. All animals recovered well after surgery with no adverse events noted; the membranes were biocompatible in the model used and were associated with improved bone healing when compared with sham operated sites. An initial inflammatory infiltrate was noted, but given the presence of foreign material and wound healing, this is to be expected and no unusual features were noted. Further work would be required to evaluate membrane degradation and longterm tissue responses to the membranes, and the possibility to use the proposed functionalized membrane as layer of a bi-or multiphasic scaffold for bone tissue engineering, as proposed by Ivanovski and co-workers. [43] 
Conclusion
We have demonstrated the utility of LbL to assemble structures characterized by tailored morphological, chemical, and biological features in tissue engineering. The advantages of this low temperature nanoencapsulation technology are evident, as sensitive molecules may be incorporated for predictable release without loss of biofunctionality. The LbL-modified membrane was shown to be both more biocompatible and able to impart an increase in the expression of the ALP activity and two major bone-specific proteins, osteopontin and osteocalcin, compared with all control materials. The functionalized membrane reported here is a substantial improvement on existing commercial devices on account of its degradability and greatly enhanced osteoconductivity via direct interaction of the biomaterial surface with cells in order to enhance tissue regeneration and healing. This is the first report of LbL being employed successfully to encourage bone tissue regeneration in vivo. It was concluded that the multilayer nanoscale encapsulation of biofunctional peptides using an LbL approach has great potential as an innovative manufacturing process to substantially improve bone tissue regeneration when using orthopedic and craniofacial medical devices.
Experimental Section
Materials: Calcium hydroxide, phosphoric acid (85 wt%, >99% pure), docusate sodium salt (DSS), PLGA (LA/GA ratio (75/25), M w = 66-107 kDa), ε-maleimidocaproic acid (EMCA), N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC), PSS (average M w = 70 kDa), N-hydroxysuccinimide (NHS), and ethylenediamine (ED) were supplied from Sigma-Aldrich, UK. PAH was supplied from Alfa Aesar, UK. The bone peptide sequences (N-acetyl-CFHRRIKA-amide, N-acetyl-CKRSR-amide, and N-acetyl-NSPVNSKIPKACCVPTELSAI-amide) were synthesized (purity more than 95% by analytical High performance liquid chromatography, HPLC) and supplied by Biomatik, Taiwan. Acetone (99.8%) was purchased from Fisher Scientific, UK. All materials and chemicals were used without further purification.
Electrospun Membrane Preparation: The electrospun membranes were prepared according to the following protocol. A defined amount of nHA (20-40 nm in width and 60-80 nm in length), synthesized according to the protocol described by the same authors, [44] was dissolved in acetone (20% w/w with respect to PLGA content) in ultrasonic bath stirring before the addition of the polymer. DSS surfactant (0.05% w/v) was added to improve the stability of the nanoparticle suspension in the www.advhealthmat.de
Adv. Healthcare Mater. 2017, 6, 1601182 www.advancedsciencenews.com www.advancedsciencenews.com polymeric solution. Then PLGA (20% w/v) was added at 25 °C in order to obtain a composite solution. The electrospinning parameters were optimized and membranes were prepared with a static 21G needle and a flat paper plate to collect randomly oriented nanofibers. The solution was spinnable in the following conditions: distance from tip to the metallic collector of 18 cm, a flow of 2.5 mL h −1 , and an electric potential of 20 kV. The resulting membranes, coded as PLGA/nHA, were collected, left under hood overnight to remove solvent residues.
Aminolysis: Electrospun membranes were treated by aminolysis by dipping in ED solution (0.05 m) for 15 min at 20 °C for grafting NH 2  in order to get a positive charge on the surface. Then, aminolyzed meshes were washed five times in H 2 O, dried under hood for 12 h.
Peptide Conjugation: First step of the peptide conjugation was the maleimide groups' grafting to the poly(allylamine hydrochloride) side chains: 1.5 mg of EMCA was added to 1 mL of PAH solution (2 mg PAH, 23.7 mg EDC, and 14.7 mg NHS) and left to react at 25 °C (room temperature) for 2 h. Gel filtration was performed in order to remove nonreacted reactants and additional by-products. Then, the peptide sequences were grafted to PAH-g-EMAC by reaction between of the maleimide group with the cysteine thiol groups. The molar ratio between the maleimide groups and peptides was 2:3, and left to incubate at 4 °C for 24 h. The peptide-g-PAH was coded as PAH-P.
LbL Functionalization: The assembly of PSS/PAH-P multilayers (shown in Figure 1A ) was performed at 25 °C. The polyelectrolytes were dissolved in order to obtain 5 mg mL −1 solutions in 0.1 m NaCl with a pH of around 4.6. The ζ-potentials of the polyelectrolyte solutions were measured by laser Doppler electrophoresis (Zetasizer Nano, Malvern instrument, USA). Aminolyzed membranes (size 5 × 5 cm and thickness ≈180 µm) were dipped first in PSS solution (5 mL) for 15 min. Then, they were washed in water containing 0.1 m NaCl at pH 4.6 for 5 min. Then, the membranes were finally soaked in PAH-P solution (5 mL) for 15 min followed with water washing step using the same parameters described before. This dipping process was repeated for seven cycles for creating 14 layers (seven bilayers of PSS/PAH-P) ( Figure 1B) . Finally, the membranes were washed with distilled water for 10 min. The samples were left to dry under hood overnight and stored in the fridge at 3 °C.
Physicochemical Characterization: The morphological analysis of the samples before and after LbL assembly was performed by SEM (LEO 1450VP). Membrane was coated with gold under vacuum (100 s) by Agar auto sputter coater. The diameters of the fibers and the pores were evaluated on at least five SEM images using ImageJ software. EDS analysis had been performed by using a benchtop SEM-equipped with EDS (Hitachi TM3030). Surface composition of the membranes was analyzed by XPS and ATR-FTIR. XPS spectra were acquired on Theta Probe (Thermo Scientific, UK), equipped with a microfocused AlKa X-ray source (1486.6 eV), operated with a 400 µm spot size (100 W power). Process parameters were: 200 eV pass energy, 1 eV step size, and 50 ms dwell time in not angle-resolved lens mode. At least three single areas were evaluated on each membrane surface. Moreover, high resolution spectra were acquired with 40 eV pass energy, 0.1 eV step size, and 200 ms as dwell time.
ATR-FTIR spectra were acquired in a wavenumber range of 4000-550 cm −1 using a Nicolet iS10 spectrometer (4 cm −1 resolution and 32 scans).
Dissolution in vitro tests were performed after immersion in 5 mL of PBS solution at 37 °C for different time points (two, four, and six weeks) with a PBS refresh every 2 d.
Cell Tests: In vitro cell tests were performed on pure electrospun composite membranes, LbL functionalized meshes without and with addition of peptides. Preliminary to the seeding of cells, membranes (φ ≈ 1.2 cm diameter discs) were sterilized using UV light for 4 h in 24-well plates and rinsed five times with PBS. Rat bone marrow stromal cells (BM-MSCs) were grown in a controlled atmosphere (5% CO 2 and T = 37 °C) in Iscove's modified Dulbecco's Modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (Sigma-Aldrich), 2 × 10 −3 m l-glutamine (Sigma-Aldrich), penicillin (100 U mL −1 ), streptomycin (100 µg mL −1 ; Sigma-Aldrich), and 0.1 × 10 −3 m nonessential amino acids (Lonza, UK) for 7 d. This medium condition is considered as basal. For all experiments, cells from up to two passages were used. A number of 30 000 cells were seeded onto the samples in 1 mL DMEM.
After 3 and 7 d of cell culture, the medium was removed and the samples were transferred to new 24-well plates; after addition of 10% PrestoBlue solution (5 mg mL −1 in DMEM; Fisher Scientific), the multiwell plates were kept in incubation for 1 h at 37 °C. After the supernatant removal, the solution (now dark blue) was transferred in 96-well plates (0.2 mL) and quantified spectrophotometrically at 560 nm (Leica DM2500). PicoGreen dsDNA reagent (Invitrogen, USA) was used to calculate the cell number for each sample in order to make a correct normalization of the fluorescence values. After each culturing period, the membranes were washed with PBS and then incubated at 37 °C for 3 h followed by freezing step at −80 °C for at least overnight in ultrapure water (1 mL) to ensure cell lysis. The assay was performed according to the manufacturer's protocol. And the fluorescence was determined at an excitation wavelength of 485 nm and emission wavelength of 528 nm. The mean ± standard deviation (SD) was calculated for five tests.
After 21 d of cell culture, BM-MSC differentiation was evaluated in basal (as described before) and osteogenic medium (after one week of cell seeding consisting of basal medium plus 50 µg mL −1 ascorbic acid, 10 −8 m dexamethasone (Sigma-Aldrich), and 10 × 10 −3 m β-glycerophosphate (Fluka Biochemika)). Alkaline phosphatase activity was evaluated after 7, 14, and 21 d by adding 500 µL alkaline buffer solution and 0.5 mL of stock substrate solution (40 mg p-nitrophenyl phosphate disodium, Sigma-Aldrich) to 100 µL of each lysate sample (obtained following the same protocol described for the PicoGreen assay), diluted in 10 mL of distilled H 2 O for 1 h at 37 °C. The p-nitrophenol production was analyzed by monitoring the solution absorbance using Leica DM2500 at 410 nm. PicoGreen dsDNA reagent (Invitrogen, USA) was used to calculate the cell number for each sample in order to make a correct normalization of the ALP absorbance values. The mean ± standard deviation was calculated for three tests.
OP and OC protein expression of BM-MSCs was assessed by immunoassay technique to evaluate the osteoblast differentiation. The concentration of OP and OC was determined for all time culture periods, using the lysates used for DNA quantification by PicoGreen. OP quantitative determination was performed by the use of Mouse/ Rat Osteopontin Quantikine ELISA Kit (R&D Systems, UK). In brief, 50 µL of assay diluent RD1W and 50 µL of standard (2500-39 pg mL −1 ), control and membrane were added into to the multiwell plate and kept to incubate at 25 °C for 2 h. After four washing steps, 100 µL of Mouse/ Rat OPN conjugated was added and incubated at 25 °C for 2 h. The sandwich complex was rinsed four times in order to react with 100 µL of substrate solution before adding 100 µL of stop solution. Finally, the optical density was determined at 450 nm and concentration of OP was obtained from standard curve plot. OC quantitative determination was performed by the use of Rat Gla-Osteocalcin High Sensitive EIA kit (Takara Clontech, Japan). In brief, 100 µL of samples and standard solution (16-0.25 ng mL −1 ) were incubated for 1 h at 37 °C with the capture-antibody, rat osteocalcin C-terminus-specific antibody. After OC capture and three washing steps, 100 µL of the enzyme-labeled antibody (GlaOC4-30) specific to Gla-OC was incubated at room temperature for 1 h. The sandwich complex was rinsed four times and allowed to react with 100 µL of substrate solution for 10-15 min. Finally, after adding the stop solution, the optical density was determined at 450 nm and concentration of OC was obtained from standard curve plot. OP and OC content was calculated by normalizing OP or OC concentration per DNA concentration for each condition and time point.
In Vivo Tests: The potential of enhanced bone regeneration in vivo was assessed by implantation of the constructs into 4.5 mm ∅ defects created in the crania of adult male Wistar rats (the average weight at the time of surgery was 320 g). The rats were assigned to one of three experimental groups (PLGA/nHA, 14L, and 14L_P), each of which comprised three animals. General anesthesia was induced and maintained using isoflurane in oxygen; after induction of anesthesia, a single dose of 0.05 mL Carprofen (Rimadyl, Pfizer Ltd., Sandwich, Kent, UK) was given by subcutaneous injection.
www.advhealthmat.de
Adv. Healthcare Mater. 2017, 6, 1601182 
www.advancedsciencenews.com
A midline incision was made over the cranial vault and the skin and periosteum reflected to reveal the skull. A single circular defect of 4.5 mm diameter was made on each side of the midline using a diamond tipped surgical bur with saline irrigation. A sample of test membrane was placed over one defect and the other left untreated to act as an internal control. The periosteum and skin were carefully repositioned to avoid moving the membrane and wounds were closed with resorbable sutures (Vicryl, Ethicon Ltd., Edinburgh, UK) and the animals were allowed to recover before returning to clean cages.
Animals were housed in groups of three and preserved under standard laboratory conditions with free access to food and water. After four weeks, surgery animals were sacrificed using a schedule one method and the heads removed and placed in formalin for fixation prior to processing for micro-CT and histological processing. Specifically, trimmed specimens were scanned using a desktop microtomograph (Sky Scan 1172, Aartselaar, Belgium) through 360° at a setting 1 voxel = 10 µm. The voltage used was 70 kV, the current was 130 µA, and the aluminum filter was set at 0.5 mm. The scan was collected using the medium camera (2000 × 1048), 0.7 rotations with ×2 averaging. Reconstruction was done using NRecon (SkyScan1172, Aartselaar, Belgium) by correcting for ring artefacts and 15% for beam hardening. The data were segmented and analyzed in CT Analyzer (Bruker software) using threshold level 60-255. The new bone formation was calculated as a percentage bone volume/tissue volume in 4.5 mm ∅ × 0.7 mm depth within the defect. A 3D image of each sample was created in CTvox (ver. 3 Sky scan, Bruker) using the transfer function "Steph bone cortical.tf" (Dr. S. Borg, University of Sheffield).
Trimmed specimens were decalcified and processed to produce hematoxylin and eosin stained sections for conventional light microscopy; histological images were collected on Aperio scan (Leica Microscopes UK ltd.).
Statistical Analysis: Tests were performed at least three times for each membrane. All data were expressed as mean ± SD. Statistical analysis was determined by using Graph pad Prism 6 software. The statistical differences between groups were calculated using Kruskal-Wallis one way analysis of variance on ranks. Statistical significance was declared at *p < 0.05, **p < 0.001, and ***p < 0.0001.
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